Nicolas Skuli

Nicolas Skuli

Auto-generated profile, based on publicly available information

Nicolas Skuli

University of Pennsylvania 1 Philadelphia, PA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
RRRomain Riscal
Romain Riscal
SGSarah M. Gardner
Sarah M. Gardner
NCNathan J. Coffey
Nathan J. Coffey
MCMadeleine Carens
Madeleine Carens
CMClementina A. Mesaros
Clementina A. Mesaros
MSM. Celeste Simon
M. Celeste Simon
Clear cell renal cell carcinoma (ccRCC) incidence has risen steadily over the last decade. Elevated lipid uptake and storage is required for ccRCC cell viability. As stored cholesterol is the most abundant component in ccRCC intracellular lipid droplets, it may also play an important role in ccRCC cellular homeostasis. In support of this hypothesis, ccRCC cells acquire exogenous cholesterol through the high-density lipoprotein receptor SCARB1, inhibition or suppression of which induces apoptosis. Here, we showed that elevated expression of 3 beta-hydroxy steroid dehydrogenase type 7 (HSD3B7), which metabolizes cholesterol-derived oxysterols in the bile acid biosynthetic pathway, is also essential for ccRCC cell survival. Development of an HSD3B7 enzymatic assay and screening for small-molecule inhibitors uncovered the compound celastrol as a potent HSD3B7 inhibitor with low micromolar activity. Repressing HSD3B7 expression genetically or treating ccRCC cells with celastrol resulted in toxic oxysterol accumulation, impaired proliferation, and increased apoptosis in vitro and in vivo. These data demonstrate that bile acid synthesis regulates cholesterol homeostasis in ccRCC and identifies HSD3B7 as a plausible therapeutic target. Significance: The bile acid biosynthetic enzyme HSD3B7 is essential for ccRCC cell survival and can be targeted to induce accumulation of cholesterol-derived oxysterols and apoptotic cell death.

9 February 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YLYing Liu
Ying Liu
IMIleana Murazzi
Ileana Murazzi
AFAshley M. Fuller
Ashley M. Fuller
HPHehai Pan
Hehai Pan
VIValerie M. Irizarry-Negron
Valerie M. Irizarry-Negron
TETzipora S.Karin Eisinger-Mathason
Tzipora S.Karin Eisinger-Mathason
Intratumoral hypoxia correlates with metastasis and poor survival in patients with sarcoma. Using an impedance sensing assay and a zebrafish intravital microinjection model, we demonstrated here that the hypoxia-inducible collagen-modifying enzyme lysyl hydroxylase PLOD2 and its substrate collagen type VI (COLVI) weaken the lung endothelial barrier and promote transendothelial migration. Mechanistically, hypoxia-induced PLOD2 in sarcoma cells modified COLVI, which was then secreted into the vasculature. Upon reaching the apical surface of lung endothelial cells, modified COLVI from tumor cells activated integrin β1 (ITGβ1). Furthermore, activated ITGβ1 colocalized with Kindlin2, initiating their interaction with F-actin and prompting its polymerization. Polymerized F-actin disrupted endothelial adherens junctions and induced barrier dysfunction. Consistently, modified and secreted COLVI was required for the late stages of lung metastasis in vivo. Analysis of patient gene expression and survival data from The Cancer Genome Atlas (TCGA) revealed an association between the expression of both PLOD2 and COLVI and patient survival. Furthermore, high levels of COLVI were detected in surgically resected sarcoma metastases from patient lungs and in the blood of tumor-bearing mice. Together, these data identify a mechanism of sarcoma lung metastasis, revealing opportunities for therapeutic intervention. Significance: Collagen type VI modified by hypoxia-induced PLOD2 is secreted by sarcoma cells and binds to integrin β1 on endothelial cells to induce barrier dysfunction, which promotes sarcoma vascular dissemination and metastasis.

1 April 2024
Verified
Other
Open access
YLYing Liu
Ying Liu
IMIleana Murazzi
Ileana Murazzi
AFAshley M. Fuller
Ashley M. Fuller
HPHehai Pan
Hehai Pan
VIValerie M. Irizarry-Negron
Valerie M. Irizarry-Negron
TETzipora S.Karin Eisinger-Mathason
Tzipora S.Karin Eisinger-Mathason
Supplementary figures and legends

15 May 2024
Verified
Other
Open access
RRRomain Riscal
Romain Riscal
SGSarah M. Gardner
Sarah M. Gardner
NCNathan J. Coffey
Nathan J. Coffey
MCMadeleine Carens
Madeleine Carens
CMClementina A. Mesaros
Clementina A. Mesaros
MSM. Celeste Simon
M. Celeste Simon
Figure S9 from Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell Carcinoma

1 April 2024
Verified
Other
Open access
YLYing Liu
Ying Liu
IMIleana Murazzi
Ileana Murazzi
AFAshley M. Fuller
Ashley M. Fuller
HPHehai Pan
Hehai Pan
VIValerie M. Irizarry-Negron
Valerie M. Irizarry-Negron
TETzipora S.Karin Eisinger-Mathason
Tzipora S.Karin Eisinger-Mathason
Intratumoral hypoxia correlates with metastasis and poor survival in patients with sarcoma. Using an impedance sensing assay and a zebrafish intravital microinjection model, we demonstrated here that the hypoxia-inducible collagen-modifying enzyme lysyl hydroxylase PLOD2 and its substrate collagen type VI (COLVI) weaken the lung endothelial barrier and promote transendothelial migration. Mechanistically, hypoxia-induced PLOD2 in sarcoma cells modified COLVI, which was then secreted into the vasculature. Upon reaching the apical surface of lung endothelial cells, modified COLVI from tumor cells activated integrin β1 (ITGβ1). Furthermore, activated ITGβ1 colocalized with Kindlin2, initiating their interaction with F-actin and prompting its polymerization. Polymerized F-actin disrupted endothelial adherens junctions and induced barrier dysfunction. Consistently, modified and secreted COLVI was required for the late stages of lung metastasis in vivo. Analysis of patient gene expression and survival data from The Cancer Genome Atlas (TCGA) revealed an association between the expression of both PLOD2 and COLVI and patient survival. Furthermore, high levels of COLVI were detected in surgically resected sarcoma metastases from patient lungs and in the blood of tumor-bearing mice. Together, these data identify a mechanism of sarcoma lung metastasis, revealing opportunities for therapeutic intervention.Significance:Collagen type VI modified by hypoxia-induced PLOD2 is secreted by sarcoma cells and binds to integrin β1 on endothelial cells to induce barrier dysfunction, which promotes sarcoma vascular dissemination and metastasis.

15 May 2024
Verified
Other
Open access
RRRomain Riscal
Romain Riscal
SGSarah M. Gardner
Sarah M. Gardner
NCNathan J. Coffey
Nathan J. Coffey
MCMadeleine Carens
Madeleine Carens
CMClementina A. Mesaros
Clementina A. Mesaros
MSM. Celeste Simon
M. Celeste Simon
Figure S2 from Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell Carcinoma